Your browser doesn't support javascript.
loading
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study.
Dewidar, Omar; Bondok, Mostafa; Abdelrazeq, Leenah; Aliyeva, Khadija; Solo, Karla; Welch, Vivian; Brignardello-Petersen, Romina; Mathew, Joseph L; Hazlewood, Glen; Pottie, Kevin; Hartling, Lisa; Khalifa, Dina Sami; Duda, Stephanie; Falavigna, Maicon; Khabsa, Joanne; Lotfi, Tamara; Petkovic, Jennifer; Elliot, Sarah; Chi, Yuan; Parker, Roses; Kristjansson, Elizabeth; Riddle, Alison; Darzi, Andrea J; Magwood, Olivia; Saad, Ammar; Rada, Gabriel; Neumann, Ignacio; Loeb, Mark; Reveiz, Ludovic; Mertz, Dominik; Piggott, Thomas; Turgeon, Alexis F; Schünemann, Holger; Tugwell, Peter.
Afiliación
  • Dewidar O; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: Odewi090@uottawa.ca.
  • Bondok M; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Abdelrazeq L; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Faculty of Health Sciences, Carleton University, Ottawa, Ontario, Canada.
  • Aliyeva K; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
  • Solo K; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Welch V; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Brignardello-Petersen R; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Mathew JL; Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
  • Hazlewood G; Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Pottie K; Department of Family Medicine, Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
  • Hartling L; Alberta Research Centre for Health Evidence and Cochrane Child Health, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Khalifa DS; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Duda S; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Falavigna M; National Institute for Health Technology Assessment, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Khabsa J; Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
  • Lotfi T; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Petkovic J; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Elliot S; Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Cochrane Child Health, Department of Pediatrics, University of Alberta, Alberta, Canada.
  • Chi Y; Beijing Yealth Technology Co., Ltd, Beijing, China; Cochrane Campbell Global Ageing Partnership, London, UK.
  • Parker R; The Cochrane Collaboration, London, UK.
  • Kristjansson E; School of Psychology, Faculty of Social Sciences, University of Ottawa, Ottawa, Ontario, Canada.
  • Riddle A; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Darzi AJ; Department of Health Research Methods, Evidence, and Impact and Anesthesia, McMaster University, Hamilton, Ontario, Canada.
  • Magwood O; Bruyère Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ontario, Canada.
  • Saad A; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Rada G; Epistemonikos Foundation, Santiago, Chile; UC Evidence Centre, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Neumann I; School of Medicine, Universidad San Sebastián, Santiago, Chile.
  • Loeb M; Departments of Pathology and Molecular Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Reveiz L; Department of Evidence and Intelligence for Action in Health and Incident Management System for COVID-19, WHO Regional Office for the Americas/Pan American Health Organization, Washington, DC, USA.
  • Mertz D; Department of Medicine and Department of Health Research Methods, McMaster University, Hamilton, Ontario, Canada.
  • Piggott T; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Family Medicine, Queens University, Kingston, Ontario, Canada; Peterborough Public Health, Peterborough, Ontario, Canada.
  • Turgeon AF; CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma-Emergency-Critical Care Medicine), Québec City, Quebec, Canada; Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec
  • Schünemann H; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommenda
  • Tugwell P; Department of Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
J Clin Epidemiol ; 161: 116-126, 2023 09.
Article en En | MEDLINE | ID: mdl-37562727
ABSTRACT
BACKGROUND AND

OBJECTIVE:

To identify COVID-19 actionable statements (e.g., recommendations) focused on specific disadvantaged populations in the living map of COVID-19 recommendations (eCOVIDRecMap) and describe how health equity was assessed in the development of the formal recommendations.

METHODS:

We employed the place of residence, race or ethnicity or culture, occupation, gender or sex, religion, education, socio-economic status, and social capital-Plus framework to identify statements focused on specific disadvantaged populations. We assessed health equity considerations in the evidence to decision frameworks (EtD) of formal recommendations for certainty of evidence and impact on health equity criteria according to the Grading of Recommendations, Assessment, Development, and Evaluations criteria.

RESULTS:

We identified 16% (124/758) formal recommendations and 24% (186/819) good practice statements (GPS) that were focused on specific disadvantaged populations. Formal recommendations (40%, 50/124) and GPS (25%, 47/186) most frequently focused on children. Seventy-six percent (94/124) of the recommendations were accompanied with EtDs. Over half (55%, 52/94) of those considered indirectness of the evidence for disadvantaged populations. Considerations in impact on health equity criterion most frequently involved implementation of the recommendation for disadvantaged populations (17%, 16/94).

CONCLUSION:

Equity issues were rarely explicitly considered in the development COVID-19 formal recommendations focused on specific disadvantaged populations. Guidance is needed to support the consideration of health equity in guideline development during health emergencies.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Equidad en Salud / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Equidad en Salud / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2023 Tipo del documento: Article